Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Micamlo

Study type: Observational

Funder types: Industry

Identifiers

NCT01353274

1235.38

Details and patient eligibility

About

Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension

Enrollment: 1,157 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and Female patients with hypertension who did not receive of MICAMLO Combination Tablets AP before the start of the study

Exclusion criteria

• Patients with a history of hypersensitivity to any ingredient of Micamlo Combination Tablets AP and dihydropyridine derivatives
• Pregnant woman or possibly pregnant woman
• Patients with extremely poor bile secretion or patients with serious hepatic disorder

Trial design

1,157 participants in 1 patient group

Patients with hypertension

Treatment:

Drug: Micamlo